Variant report

Variant	nsv1014042
Chromosome Location	chr4:69599853-69667996
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr4:69610615-69611033	HepG2	liver:	n/a	n/a
2	ARID3A	chr4:69662896-69663031	HepG2	liver:	n/a	n/a
3	ARID3A	chr4:69637663-69637849	HepG2	liver:	n/a	n/a
4	ATF3	chr4:69610677-69611573	A549	lung:	n/a	n/a
5	BCL3	chr4:69610467-69611680	A549	lung:	n/a	n/a
6	BCL3	chr4:69610392-69610856	A549	lung:	n/a	n/a
7	BHLHE40	chr4:69600030-69600161	GM12878	blood:	n/a	n/a
8	BRCA1	chr4:69667559-69667568	GM12878	blood:	n/a	n/a
9	CEBPB	chr4:69608567-69608819	Hela-S3	cervix:	n/a	chr4:69608679-69608690 chr4:69608707-69608720 chr4:69608709-69608718 chr4:69608707-69608720 chr4:69608707-69608720 chr4:69608709-69608718 chr4:69608707-69608718 chr4:69608708-69608719 chr4:69608756-69608769 chr4:69608680-69608689 chr4:69608709-69608718 chr4:69608709-69608718
10	CEBPB	chr4:69605784-69605991	HepG2	liver:	n/a	n/a
11	CEBPB	chr4:69610882-69611428	A549	lung:	n/a	n/a
12	CEBPB	chr4:69608520-69608748	H1-hESC	embryonic stem cell:	n/a	chr4:69608679-69608690 chr4:69608707-69608720 chr4:69608709-69608718 chr4:69608707-69608720 chr4:69608707-69608720 chr4:69608709-69608718 chr4:69608707-69608718 chr4:69608708-69608719 chr4:69608680-69608689 chr4:69608709-69608718 chr4:69608709-69608718
13	CEBPB	chr4:69614116-69614449	Hela-S3	cervix:	n/a	n/a
14	CEBPB	chr4:69655534-69655732	HepG2	liver:	n/a	chr4:69655582-69655593 chr4:69655582-69655591
15	CEBPB	chr4:69637597-69637887	HepG2	liver:	n/a	chr4:69637743-69637754
16	CEBPB	chr4:69610635-69611552	A549	lung:	n/a	n/a
17	CEBPB	chr4:69662855-69663059	HepG2	liver:	n/a	chr4:69662889-69662902 chr4:69662889-69662902
18	CEBPB	chr4:69637609-69637853	HepG2	liver:	n/a	chr4:69637743-69637754
19	CEBPB	chr4:69614171-69614444	IMR90	lung:	n/a	n/a
20	CEBPB	chr4:69608542-69608820	IMR90	lung:	n/a	chr4:69608679-69608690 chr4:69608707-69608720 chr4:69608709-69608718 chr4:69608707-69608720 chr4:69608707-69608720 chr4:69608709-69608718 chr4:69608707-69608718 chr4:69608708-69608719 chr4:69608756-69608769 chr4:69608680-69608689 chr4:69608709-69608718 chr4:69608709-69608718
21	CEBPB	chr4:69608539-69608824	A549	lung:	n/a	chr4:69608679-69608690 chr4:69608707-69608720 chr4:69608709-69608718 chr4:69608707-69608720 chr4:69608707-69608720 chr4:69608709-69608718 chr4:69608707-69608718 chr4:69608708-69608719 chr4:69608756-69608769 chr4:69608680-69608689 chr4:69608709-69608718 chr4:69608709-69608718
22	CEBPB	chr4:69608451-69608832	HepG2	liver:	n/a	chr4:69608679-69608690 chr4:69608707-69608720 chr4:69608709-69608718 chr4:69608707-69608720 chr4:69608707-69608720 chr4:69608709-69608718 chr4:69608707-69608718 chr4:69608708-69608719 chr4:69608756-69608769 chr4:69608680-69608689 chr4:69608709-69608718 chr4:69608709-69608718
23	CEBPB	chr4:69608546-69608828	K562	blood:	n/a	chr4:69608679-69608690 chr4:69608707-69608720 chr4:69608709-69608718 chr4:69608707-69608720 chr4:69608707-69608720 chr4:69608709-69608718 chr4:69608707-69608718 chr4:69608708-69608719 chr4:69608756-69608769 chr4:69608680-69608689 chr4:69608709-69608718 chr4:69608709-69608718
24	CEBPB	chr4:69610997-69611391	A549	lung:	n/a	n/a
25	CEBPB	chr4:69643053-69643196	HepG2	liver:	n/a	chr4:69643169-69643180 chr4:69643170-69643181 chr4:69643169-69643182 chr4:69643169-69643182 chr4:69643169-69643182
26	CTCF	chr4:69667483-69667568	GM13976	blood:	n/a	n/a
27	CTCF	chr4:69639520-69639670	GM06990	blood:	n/a	n/a
28	CTCF	chr4:69667468-69667528	GM12878	blood:	n/a	n/a
29	CTCF	chr4:69627300-69627450	GM12866	blood:	n/a	n/a
30	CTCF	chr4:69667420-69667614	GM19238	blood:	n/a	n/a
31	CTCF	chr4:69626757-69626852	GM20000	blood:	n/a	n/a
32	CTCF	chr4:69667433-69667636	GM12878	blood:	n/a	n/a
33	CTCF	chr4:69667455-69667460	GM12878	blood:	n/a	n/a
34	CTCF	chr4:69664302-69664340	GM10248	blood:	n/a	n/a
35	CTCF	chr4:69667445-69667544	GM12892	blood:	n/a	n/a
36	CTCF	chr4:69667480-69667630	GM12875	blood:	n/a	n/a
37	CTCF	chr4:69667538-69667565	H1-hESC	embryonic stem cell:	n/a	n/a
38	CTCF	chr4:69601000-69601150	GM12873	blood:	n/a	n/a
39	CTCF	chr4:69639499-69639605	GM10266	blood:	n/a	n/a
40	CTCF	chr4:69645878-69645948	ProgFib	skin:	n/a	n/a
41	CTCF	chr4:69625280-69625430	GM12871	blood:	n/a	n/a
42	CTCF	chr4:69606004-69606074	Spleen_OC	spleen:	n/a	n/a
43	CTCF	chr4:69664163-69664241	GM20000	blood:	n/a	n/a
44	CTCF	chr4:69667578-69667615	H1-hESC	embryonic stem cell:	n/a	n/a
45	CTCF	chr4:69667540-69667690	GM12874	blood:	n/a	n/a
46	CTCF	chr4:69667419-69667551	GM19239	blood:	n/a	n/a
47	CTCF	chr4:69667513-69667547	MCF-7	breast:	n/a	n/a
48	CTCF	chr4:69667460-69667610	GM12865	blood:	n/a	n/a
49	CTCF	chr4:69638025-69638080	Kidney_OC	kidney:	n/a	n/a
50	CTCF	chr4:69667460-69667549	GM12891	blood:	n/a	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr4:69627049..69629916-chr4:69637911..69640559,2	K562	blood:
2	chr4:69627049..69629916-chr4:69637911..69640559,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-UGT2B15-1	chr4:69610451-69610823	XLOC_003973
2	lnc-UGT2B15-1	chr4:69613396-69613521	XLOC_003973
3	lnc-UGT2B15-1	chr4:69610363-69610823	XLOC_003973
4	lnc-UGT2B15-1	chr4:69601916-69601926	XLOC_003973
5	lnc-UGT2B15-1	chr4:69616420-69616639	XLOC_003973
6	lnc-UGT2B15-1	chr4:69616420-69616639	XLOC_003973

Variant related genes	Relation type
ENSG00000250376	TF binding region
PALLD	miRNA target sites
PAK4	miRNA target sites

Extended variants
information (count: 1833 )
Associated
traits (count: 83 )

Variant overlapped rSNPs/rCNVs (count:1833 , 50 per page) page: 1 2 3 4 5 6 7 ... 37

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs563773061	chr4:69599855-69599856	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs527823503	chr4:69599869-69599870	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs547891222	chr4:69599875-69599876	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs567492355	chr4:69599887-69599888	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs117420969	chr4:69599897-69599898	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs78493577	chr4:69599904-69599905	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs80055585	chr4:69599905-69599906	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs76609302	chr4:69599908-69599909	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs550058328	chr4:69600026-69600027	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs185262562	chr4:69600037-69600038	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs189926311	chr4:69600038-69600039	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs114048111	chr4:69600061-69600062	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs149078114	chr4:69600064-69600065	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs543334242	chr4:69600095-69600096	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs558480670	chr4:69600101-69600102	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs370520086	chr4:69600102-69600103	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs144540409	chr4:69600111-69600112	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs199971903	chr4:69600113-69600114	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs114601178	chr4:69600115-69600116	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs554214477	chr4:69600142-69600143	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs573908901	chr4:69600175-69600176	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs182562099	chr4:69600221-69600222	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs556717453	chr4:69600288-69600289	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs576706627	chr4:69600336-69600337	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs545671053	chr4:69600436-69600437	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs565165423	chr4:69600453-69600454	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs188239647	chr4:69600462-69600463	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs529097381	chr4:69600527-69600528	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs116400206	chr4:69600548-69600549	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs191748083	chr4:69600575-69600576	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs529918516	chr4:69600586-69600587	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs34912341	chr4:69600594-69600595	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs375181837	chr4:69600658-69600659	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs113274213	chr4:69600662-69600663	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs77529211	chr4:69600698-69600699	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs528626092	chr4:69600729-69600730	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs35298451	chr4:69600761-69600762	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs551892647	chr4:69600765-69600766	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs552423765	chr4:69600778-69600779	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs547654393	chr4:69600824-69600825	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs565356187	chr4:69600847-69600848	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs148314207	chr4:69600869-69600870	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs547887578	chr4:69600878-69600879	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs571686295	chr4:69600885-69600886	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs141463962	chr4:69600890-69600891	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs147048822	chr4:69600907-69600908	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs559302292	chr4:69600912-69600913	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs113501082	chr4:69600978-69600979	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs576558818	chr4:69600999-69601000	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs293409	chr4:69601023-69601024	Enhancers Flanking Active TSS Weak transcription Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance

Variant related diseases (count:83)

Disease	PMID	Source
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
lymphocytic leukemia	21291569	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Non-small cell lung cancer	21829676	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Lung cancer	18438408	CNVD
Breast cancer	17603634	CNVD
Glioblastoma multiforme	21922591	CNVD
Parkinson disease	21956041	CNVD
Mental retardation	20522426	CNVD
delayed speech	20522426	CNVD
growth disorder	20522426	CNVD
Hepatocellular carcinoma	16750200	CNVD
Myxofibrosarcoma	16751306	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Parkinson disease	18923514	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Cancer	21183584	CNVD
Breast cancer	16272173	CNVD
Multiple myeloma	16616336	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Colorectal cancer	16272173	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Lung cancer	19208797	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21785460	CNVD
Acute myeloid leukemia	21251322	CNVD
Prostate cancer	16573809	CNVD
Osteoporosis	18992858	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Myelodysplastic syndrome	21251322	CNVD
Multiple myeloma	17550852	CNVD
Graft versus host disease	20877625	CNVD
Breast cancer	21990379	CNVD
Myelofibrosis	22110671	CNVD
Osteoporosis	20877625	CNVD
Osteoporosis	19737800	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
Glioblastoma multiforme	21138945	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Oral cancer	21386901	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
small cell lung cancer	20016488	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
early-passage human iPS cells	21368824	CNVD

Chromatin state (count:153 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:69590800-69601000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
2	chr4:69596600-69600800	Weak transcription	Pancreas	Pancrea
3	chr4:69599000-69600000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
4	chr4:69599000-69600000	Active TSS	Duodenum Mucosa	Duodenum
5	chr4:69599000-69600200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
6	chr4:69599000-69600200	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
7	chr4:69599000-69600600	Enhancers	Pancreatic Islets	Pancreatic Islet
8	chr4:69599000-69601000	Enhancers	A549	lung
9	chr4:69599000-69603000	Enhancers	Rectal Mucosa Donor 31	rectum
10	chr4:69599200-69600000	Weak transcription	Fetal Intestine Small	intestine
11	chr4:69599200-69602800	Enhancers	Stomach Mucosa	stomach
12	chr4:69599600-69600600	Weak transcription	HUES48 Cell Line	embryonic stem cell
13	chr4:69599600-69600800	Active TSS	Fetal Intestine Large	intestine
14	chr4:69599800-69600200	Flanking Active TSS	Fetal Kidney	kidney
15	chr4:69599800-69600400	Flanking Active TSS	Liver	Liver
16	chr4:69599800-69600800	Flanking Active TSS	HepG2	liver
17	chr4:69599800-69601200	Active TSS	Fetal Stomach	stomach
18	chr4:69600000-69600400	Enhancers	iPS-18 Cell Line	embryonic stem cell
19	chr4:69600000-69600600	Flanking Active TSS	Duodenum Mucosa	Duodenum
20	chr4:69600000-69602800	Enhancers	Fetal Intestine Small	intestine
21	chr4:69600200-69600600	Active TSS	Rectal Mucosa Donor 29	rectum
22	chr4:69600200-69600800	Enhancers	Fetal Kidney	kidney
23	chr4:69600400-69601600	Enhancers	Liver	Liver
24	chr4:69600600-69601000	Enhancers	HUES48 Cell Line	embryonic stem cell
25	chr4:69600600-69601000	Enhancers	Duodenum Mucosa	Duodenum
26	chr4:69600600-69601400	Weak transcription	Rectal Mucosa Donor 29	rectum
27	chr4:69600800-69601200	Flanking Active TSS	Fetal Intestine Large	intestine
28	chr4:69600800-69602200	Weak transcription	Fetal Kidney	kidney
29	chr4:69600800-69602200	Enhancers	Pancreas	Pancrea
30	chr4:69600800-69602200	Enhancers	Small Intestine	intestine
31	chr4:69600800-69603800	Enhancers	HepG2	liver
32	chr4:69601000-69601200	Flanking Active TSS	Duodenum Mucosa	Duodenum
33	chr4:69601000-69601200	Enhancers	Gastric	stomach
34	chr4:69601000-69601400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
35	chr4:69601000-69602400	Weak transcription	A549	lung
36	chr4:69601200-69602400	Enhancers	Duodenum Mucosa	Duodenum
37	chr4:69601200-69602800	Enhancers	Fetal Intestine Large	intestine
38	chr4:69601400-69601600	Enhancers	Rectal Mucosa Donor 29	rectum
39	chr4:69601400-69602600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
40	chr4:69601800-69602000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
41	chr4:69602000-69602200	Enhancers	Gastric	stomach
42	chr4:69602200-69602600	Enhancers	Fetal Kidney	kidney
43	chr4:69602200-69604000	Weak transcription	Gastric	stomach
44	chr4:69602400-69602800	Enhancers	A549	lung
45	chr4:69602600-69602800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
46	chr4:69602600-69602800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
47	chr4:69602600-69603800	Weak transcription	Fetal Kidney	kidney
48	chr4:69602800-69604000	Weak transcription	Stomach Mucosa	stomach
49	chr4:69602800-69613400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
50	chr4:69603800-69604000	Enhancers	Fetal Kidney	kidney

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links